Form 8-K - Current report:
SEC Accession No. 0001193125-25-142830
Filing Date
2025-06-18
Accepted
2025-06-18 17:30:11
Documents
19
Period of Report
2025-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d44604d8k.htm   iXBRL 8-K 36122
2 EX-1.1 d44604dex11.htm EX-1.1 223887
3 EX-4.1 d44604dex41.htm EX-4.1 62346
4 EX-4.2 d44604dex42.htm EX-4.2 78546
5 EX-5.1 d44604dex51.htm EX-5.1 12185
6 EX-99.1 d44604dex991.htm EX-99.1 9322
7 EX-99.2 d44604dex992.htm EX-99.2 10326
11 GRAPHIC g44604g0618213659365.jpg GRAPHIC 2755
  Complete submission text file 0001193125-25-142830.txt   674860

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA bmea-20250617.xsd EX-101.SCH 2866
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmea-20250617_lab.xml EX-101.LAB 18738
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmea-20250617_pre.xml EX-101.PRE 11718
21 EXTRACTED XBRL INSTANCE DOCUMENT d44604d8k_htm.xml XML 3760
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40335 | Film No.: 251057963
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)